Oxford Biomedica plc

LSE:OXB 株式レポート

時価総額：UK£426.7m

Oxford Biomedica マネジメント

マネジメント 基準チェック /24

Oxford Biomedica's CEO is Frank Mathias, appointed in Mar 2023, has a tenure of 1.67 years. total yearly compensation is £520.00K, comprised of 88.1% salary and 11.9% bonuses, including company stock and options. directly owns 0.019% of the company’s shares, worth £80.99K. The average tenure of the management team and the board of directors is 1.2 years and 3.7 years respectively.

主要情報

Frank Mathias

最高経営責任者

UK£520.0k

報酬総額

CEO給与比率88.1%
CEO在任期間1.7yrs
CEOの所有権0.02%
経営陣の平均在職期間1.2yrs
取締役会の平均在任期間3.7yrs

経営陣の近況

Recent updates

Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oct 19
Is Oxford Biomedica (LON:OXB) Using Debt Sensibly?

Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Aug 23
Oxford Biomedica plc (LON:OXB) Not Doing Enough For Some Investors As Its Shares Slump 28%

Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 15
Is Oxford Biomedica plc (LON:OXB) Expensive For A Reason? A Look At Its Intrinsic Value

Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Oct 06
Is Oxford Biomedica (LON:OXB) Using Too Much Debt?

Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

May 02
Investors Shouldn't Be Too Comfortable With Oxford Biomedica's (LON:OXB) Robust Earnings

We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

Jun 29
We're Not Worried About Oxford Biomedica's (LON:OXB) Cash Burn

CEO報酬分析

Oxford Biomedica の収益と比較して、Frank Mathias の報酬はどのように変化したか？
日付総報酬給与会社業績
Jun 30 2024n/an/a

-UK£142m

Mar 31 2024n/an/a

-UK£150m

Dec 31 2023UK£520kUK£458k

-UK£157m

報酬と市場: Frank's total compensation ($USD674.83K) is below average for companies of similar size in the UK market ($USD1.01M).

報酬と収益: Insufficient data to compare Frank's compensation with company performance.

CEO（最高経営責任者

Frank Mathias (62 yo)

1.7yrs

在職期間

UK£520,000

報酬

Dr. Frank Mathias is Chief Executive Officer and Director of Oxford Biomedica plc from March 27, 2023. Dr. Mathias was the Chief Executive Officer of Rentschler Biopharma SE from April 2016 until March 202...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
£ 81.0k
Lucinda Crabtree
CFO & Directorless than a yearデータなしデータなし
Thierry Cournez
Chief Operating Officer1.1yrsデータなしデータなし
Sophia Bolhassan
Head of Investor Relationsno dataデータなしデータなし
Natalie Walter
General Counsel & Company Secretary5.5yrsデータなしデータなし
Lisa James
Chief People Officer2.6yrsデータなしデータなし
Kyriacos Mitrophanous
Chief Innovation Officerless than a yearデータなしデータなし
Kati Hudson
Head of Intellectual Property and Contractsno dataデータなしデータなし
Sebastien Ribault
Chief Business Officer2yrsデータなしデータなし
Mark Caswell
Site Head of UK Operations1.3yrsデータなしデータなし
Stephanie Colloud
Site Head & GM of France Operationsless than a yearデータなしデータなし
Sabine Sydow
Chief of Staffless than a yearデータなしデータなし

1.2yrs

平均在職期間

51yo

平均年齢

経験豊富な経営陣: OXB's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

取締役

名称ポジション在職期間報酬所有権
Frank Mathias
CEO & Director1.7yrsUK£520.00k0.019%
£ 81.0k
Lucinda Crabtree
CFO & Directorless than a yearデータなしデータなし
Frederic Doliveux
Non-Executive Chair4.4yrsUK£225.00k0.35%
£ 1.5m
William Langston
Member of Scientific Advisory Boardno dataデータなしデータなし
Peter Stern
Member of Scientific Advisory Boardno dataデータなしデータなし
Krystof Bankiewicz
Member of Scientific Advisory Boardno dataデータなしデータなし
Leone Patterson
Independent Non-Executive Director1.5yrsUK£87.00k0.012%
£ 50.4k
Heather Preston
Independent Non-Executive Director6.7yrsUK£140.00k0.017%
£ 74.1k
Dame Davies
Senior Independent Director3.7yrsUK£73.00k0.00095%
£ 4.1k
Stuart Henderson
Independent Vice Chair8.4yrsUK£85.00k0.010%
£ 44.0k
Robert Ghenchev
Non-Executive Director5.4yrsデータなしデータなし
Namrata Patel
Independent Non-Executive Director2.6yrsUK£65.00k0.0087%
£ 37.1k

3.7yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: OXB's board of directors are considered experienced (3.7 years average tenure).